Mechanical circulatory support devices are used to offer short-term support for patients with cardiogenic shock. However, these devices are not without complications, and the risk and management of each must be closely considered. We discuss an infrequent complication of the percutaneous right heart pump and review complications reported to the U.S. Food and Drug Administration. ().
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350931 | PMC |
http://dx.doi.org/10.1016/j.jaccas.2022.04.026 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!